Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026)

Zai Lab (ZLAB) posted Interest & Investment Income of $6.4 million for Q1 2026, down 11.12% sequentially from $7.3 million in Q4 2025, and down 25.09% YoY from $8.6 million in Q1 2025.

Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026) Analysis & Trends

Zai Lab has reported Interest & Investment Income for 7 years, with the latest figure at $6.4 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 25.09% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.9 million (down 14.32% YoY) and the FY2025 annual result came in at $33.0 million, down 10.93% from the prior year.
  • Interest & Investment Income retreated to $6.4 million in Q1 2026 per ZLAB's latest filing, from $7.3 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $10.3 million in Q4 2023 and troughed at $188000.0 in Q1 2022.
  • A 5-year average of $7.7 million and a median of $9.0 million in 2024 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2023 and 2026: Interest & Investment Income surged 5342.55% in 2023, then dropped 25.09% in 2026.
  • Over 5 years, Interest & Investment Income stood at $9.3 million in 2022, then rose by 10.24% to $10.3 million in 2023, then declined by 11.8% to $9.1 million in 2024, then slipped by 20.18% to $7.3 million in 2025, then declined by 11.12% to $6.4 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $6.4 million, $7.3 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 48.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 35.58 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 27.90 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 5.13 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 28.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 10.98 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 5.88 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.88 Mn
Mar 31, 2026 6.45 Mn
Dec 31, 2025 7.25 Mn
Sep 30, 2025 8.35 Mn
Jun 30, 2025 8.84 Mn
Mar 31, 2025 8.61 Mn
Dec 31, 2024 9.09 Mn
Sep 30, 2024 9.03 Mn
Jun 30, 2024 9.33 Mn
Mar 31, 2024 9.66 Mn
Dec 31, 2023 10.30 Mn
Sep 30, 2023 9.17 Mn
Jun 30, 2023 10.09 Mn
Mar 31, 2023 10.23 Mn
Dec 31, 2022 9.35 Mn
Sep 30, 2022 3.87 Mn
Jun 30, 2022 1.18 Mn
Mar 31, 2022 188,000.00
Dec 31, 2021 1.02 Mn
Sep 30, 2021 713,000.00